ENDRA Life Sciences Cash from Financing (TTM) Insights

ENDRA Life Sciences Inc (NDRA)

0.2477 +0.01 (+6.13%) USD | NASDAQ | Apr 19, 16:00

0.2477 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	7.518M
September 30, 2023	5.847M
June 30, 2023	4.733M
March 31, 2023	7.546M
December 31, 2022	8.400M
September 30, 2022	8.721M
June 30, 2022	9.217M
March 31, 2022	1.672M
December 31, 2021	13.40M
September 30, 2021	18.65M
June 30, 2021	23.32M
March 31, 2021	24.42M
December 31, 2020	11.88M
September 30, 2020	12.15M
June 30, 2020	9.472M

Date	Value
March 31, 2020	8.374M
December 31, 2019	8.335M
September 30, 2019	10.23M
June 30, 2019	7.737M
March 31, 2019	8.672M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017	8.766M
September 30, 2017	8.766M
June 30, 2017	8.953M
March 31, 2017	1.611M
December 31, 2016	1.441M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.672M

Minimum

Mar 2022

24.42M

Maximum

Mar 2021

10.61M

Average

8.721M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks